Literature DB >> 23384677

Rapid deep sequencing of patient-derived HIV with ion semiconductor technology.

Max W Chang1, Glenn Oliveira, Jinyun Yuan, Jason F Okulicz, Samuel Levy, Bruce E Torbett.   

Abstract

The development of next-generation sequencing technologies has facilitated the study of HIV drug resistance evolution. However, the high capacity and per-run cost of many sequencers is not ideal for viral sequencing unless many samples are analyzed simultaneously. Ion semiconductor sequencing has recently emerged as a flexible, lower-cost alternative with short runtime. This paper describes the use of Ion Torrent devices for deep sequencing of drug resistant HIV samples. High levels of sequencing coverage were obtained in HIV Gag and protease, allowing the detection of mutations at low frequencies.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384677      PMCID: PMC3608812          DOI: 10.1016/j.jviromet.2013.01.019

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

Review 1.  2011 update of the drug resistance mutations in HIV-1.

Authors:  Victoria A Johnson; Vincent Calvez; Huldrych F Günthard; Roger Paredes; Deenan Pillay; Robert Shafer; Annemarie M Wensing; Douglas D Richman
Journal:  Top Antivir Med       Date:  2011-11

2.  Performance comparison of benchtop high-throughput sequencing platforms.

Authors:  Nicholas J Loman; Raju V Misra; Timothy J Dallman; Chrystala Constantinidou; Saheer E Gharbia; John Wain; Mark J Pallen
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

Review 3.  HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

Authors:  Robert W Shafer; Soo-Yon Rhee; Deenan Pillay; Veronica Miller; Paul Sandstrom; Jonathan M Schapiro; Daniel R Kuritzkes; Diane Bennett
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

4.  Field guide to next-generation DNA sequencers.

Authors:  Travis C Glenn
Journal:  Mol Ecol Resour       Date:  2011-05-19       Impact factor: 7.090

5.  Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Authors:  Sarah Palmer; Mary Kearney; Frank Maldarelli; Elias K Halvas; Christian J Bixby; Holly Bazmi; Diane Rock; Judith Falloon; Richard T Davey; Robin L Dewar; Julia A Metcalf; Scott Hammer; John W Mellors; John M Coffin
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 6.  Is resistance futile?

Authors:  Victoria D Kutilek; Dennis A Sheeter; John H Elder; Bruce E Torbett
Journal:  Curr Drug Targets Infect Disord       Date:  2003-12

7.  Highly sensitive and specific detection of rare variants in mixed viral populations from massively parallel sequence data.

Authors:  Alexander R Macalalad; Michael C Zody; Patrick Charlebois; Niall J Lennon; Ruchi M Newman; Christine M Malboeuf; Elizabeth M Ryan; Christian L Boutwell; Karen A Power; Doug E Brackney; Kendra N Pesko; Joshua Z Levin; Gregory D Ebel; Todd M Allen; Bruce W Birren; Matthew R Henn
Journal:  PLoS Comput Biol       Date:  2012-03-15       Impact factor: 4.475

8.  Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.

Authors:  Matthew R Henn; Christian L Boutwell; Patrick Charlebois; Niall J Lennon; Karen A Power; Alexander R Macalalad; Aaron M Berlin; Christine M Malboeuf; Elizabeth M Ryan; Sante Gnerre; Michael C Zody; Rachel L Erlich; Lisa M Green; Andrew Berical; Yaoyu Wang; Monica Casali; Hendrik Streeck; Allyson K Bloom; Tim Dudek; Damien Tully; Ruchi Newman; Karen L Axten; Adrianne D Gladden; Laura Battis; Michael Kemper; Qiandong Zeng; Terrance P Shea; Sharvari Gujja; Carmen Zedlack; Olivier Gasser; Christian Brander; Christoph Hess; Huldrych F Günthard; Zabrina L Brumme; Chanson J Brumme; Suzane Bazner; Jenna Rychert; Jake P Tinsley; Ken H Mayer; Eric Rosenberg; Florencia Pereyra; Joshua Z Levin; Sarah K Young; Heiko Jessen; Marcus Altfeld; Bruce W Birren; Bruce D Walker; Todd M Allen
Journal:  PLoS Pathog       Date:  2012-03-08       Impact factor: 6.823

9.  Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II.

Authors:  John Archer; Greg Baillie; Simon J Watson; Paul Kellam; Andrew Rambaut; David L Robertson
Journal:  BMC Bioinformatics       Date:  2012-03-23       Impact factor: 3.169

Review 10.  Human Immunodeficiency Virus Gag and protease: partners in resistance.

Authors:  Axel Fun; Annemarie M J Wensing; Jens Verheyen; Monique Nijhuis
Journal:  Retrovirology       Date:  2012-08-06       Impact factor: 4.602

View more
  15 in total

Review 1.  Emerging technologies for the clinical microbiology laboratory.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Targeted deep sequencing of HIV-1 using the IonTorrentPGM platform.

Authors:  Gustavo H Kijak; Eric Sanders-Buell; Elizabeth A Harbolick; Phuc Pham; Agnes L Chenine; Leigh Anne Eller; Kathleen Rono; Merlin L Robb; Nelson L Michael; Jerome H Kim; Sodsai Tovanabutra
Journal:  J Virol Methods       Date:  2014-05-04       Impact factor: 2.014

3.  CoVaMa: Co-Variation Mapper for disequilibrium analysis of mutant loci in viral populations using next-generation sequence data.

Authors:  Andrew Routh; Max W Chang; Jason F Okulicz; John E Johnson; Bruce E Torbett
Journal:  Methods       Date:  2015-09-25       Impact factor: 3.608

4.  HIV-1 Drug Resistance Assay Using Ion Torrent Next Generation Sequencing and On-Instrument End-to-End Analysis Software.

Authors:  Michael T Pyne; Keith E Simmon; Melanie A Mallory; Weston C Hymas; Jeffery Stevenson; Adam P Barker; David R Hillyard
Journal:  J Clin Microbiol       Date:  2022-06-14       Impact factor: 11.677

5.  Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?

Authors:  Richard M Gibson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

Review 6.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

7.  Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.

Authors:  Fred Kyeyune; Richard M Gibson; Immaculate Nankya; Colin Venner; Samar Metha; Juliet Akao; Emmanuel Ndashimye; Cissy M Kityo; Robert A Salata; Peter Mugyenyi; Eric J Arts; Miguel E Quiñones-Mateu
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

8.  Covariation of viral recombination with single nucleotide variants during virus evolution revealed by CoVaMa.

Authors:  Shiyi Wang; Stephanea L Sotcheff; Christian M Gallardo; Elizabeth Jaworski; Bruce E Torbett; Andrew L Routh
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

9.  Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease.

Authors:  William F Flynn; Max W Chang; Zhiqiang Tan; Glenn Oliveira; Jinyun Yuan; Jason F Okulicz; Bruce E Torbett; Ronald M Levy
Journal:  PLoS Comput Biol       Date:  2015-04-20       Impact factor: 4.475

10.  Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.

Authors:  Richard M Gibson; Ashley M Meyer; Dane Winner; John Archer; Felix Feyertag; Ezequiel Ruiz-Mateos; Manuel Leal; David L Robertson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.